Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: Atherosclerosis. 2015 May 16;241(1):176–182. doi: 10.1016/j.atherosclerosis.2015.05.006

Table 2.

Average Lp-PLA2 mass and activity by subsequent case status (n=5456)*

LpPLA2 CVD
(n=498)		 CHD
(n=346)		 CHD (Hard)
(n=215)
Mass (ng/mL)
  Cases 186 ± 43 189 ± 44 193 ± 45
  Noncases 177 ± 42 177 ± 42 177 ± 42
  p-value† 0.003 0.001 <0.001
CVD
(n=506)		 CHD
(n=349)		 CHD (Hard)
(n=217)
Activity (nmol/min/mL)
  Cases 158 ± 35 161 ± 35 161 ± 33
  Noncases 148 ± 36 148 ± 36 149 ± 37
  p-value <0.001 <0.001 0.001
*

Values are means ± SD

†

P-values compare the means between cases and noncases adjusting for age, gender and race/ethnicity.